Navigation Links
US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research
Date:8/19/2010

are proud of the team effort within the US Oncology Research network that has allowed independent community-based physicians to participate in the development of new treatments for cancer."

"There are so many lives lost to cancer," said Dr. Kolibaba. "US Oncology Research and its physician participants understand that research leads to cancer cures, that new therapies extend survival, and that carefully conducted clinical trials are the only way that progress is achieved. There is no better way to help patients than to offer new treatments. Through participation in clinical trials, physicians can do both, treating cancer patients with the best possible care and moving the field forward."

US Oncology Research is physician-led and physician-driven with a successful history of clinical depth and expertise.  

  • More than 43,000 patients have participated in US Oncology Research trials.  
  • With the approval of Tasigna, US Oncology Research has played a role in the development of 42 cancer therapies approved by the FDA in less than two decades.
  • The US Oncology Research network includes more than 80 practices in 200 locations across the U.S.
  • The network supports 14 sites that offer Phase I trials, including first-in-human trials.
  • At any given time, the network has more than 200 active trials.
  • Leadership at US Oncology Research consists of experts in a wide variety of cancer specialties including Breast Cancer, Developmental Therapeutics, Gastrointestinal Cancer, Hematologic Cancer, Gynecologic Cancer, Genitourinary Cancer, Lung Cancer, Translational Oncology Program, and Radiation Therapy.
  • 57 manuscripts from investigator-initiated studies have been published in peer-reviewed journals.
  • US Oncology Research supports the nation's largest research network specializing in Phase I-IV oncology clinical trials.  Investigator- and sponsor-initiated
    '/>"/>

SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
2. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
3. US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
4. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
5. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
6. First Coast Oncology to Offer Next Generation Proton Therapy
7. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
8. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
9. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
10. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
11. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Gene Therapy - ... , Gene therapy technologies are ... and cell therapy with genetically modified vectors. Gene ... and various routes of administration as well as ...
(Date:3/3/2015)... , March 3, 2015 ... with tools for implementing competency-based training to comply with ... DirectCourse is offering a new crosswalk tool ... (HCBS) implement competency-based training for direct service workers as ... & Medicaid Services (CMS) regulations. CMS amended ...
(Date:3/3/2015)... Md. , March 3, 2015  Synthetic Biologics, Inc. ... infections and diseases, with a focus on protecting the microbiome, ... is scheduled to present at the 27th Annual ROTH Conference ... Laguna Niguel in Dana Point, ... Tuesday, March 10, 2015 at 1:00 p.m. (Pacific Time). ...
(Date:3/3/2015)... 3, 2015  PDL BioPharma, Inc. (PDL or the ... the third of three shareholder lawsuits filed in the ... On February 2, 2015, a securities lawsuit that ... of a putative class of purchasers of the Company,s ... 2:14-CV-01526-APG-NJK (D. Nev.), was voluntarily dismissed without prejudice.  Shortly ...
Breaking Biology Technology:Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3Synthetic Biologics to Present at the 27th Annual ROTH Conference 2PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2
... Quintiles,Transnational Corp. today announced the appointment of ... Troullis had been,acting CFO since former CFO John ... Troullis joined Quintiles in 1992 as Director ... CFO, Troullis was Senior Vice President and,Worldwide Controller. ...
... Offer Regulatory ... Operations Expertise, WHIPPANY, N.J., Aug. ... services to streamline the drug,development lifecycle, today announced the expansion of ... Diego. The announcements,illustrate the company,s newly elevated focus on emerging West ...
... at the 58th Annual Meeting of ... (AASLD), TAMPA, Fla., Aug. 15 Romark Laboratories ... of Alinia(R) (nitazoxanide) for,treating chronic hepatitis C in the ... evaluate the effectiveness and safety,of Alinia tablets administered in ...
Cached Biology Technology:ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 2ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 3ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego 4Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 2Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 3Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States 4
(Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
(Date:2/5/2015)... JOLLA, Calif. , Jan. 30, 2015  It ... the great power and potential for genomic science as ... aid in disease prevention and treatment.  I was honored ... potential new, government-funded precision medicine program. ... advancing the science of genomics—from the first sequenced genome ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... North Carolina State University researcher has shown that water-gel-based ... solar cells to produce electricity. The findings prove the ... nature. They also have the potential to be less ... silicon-based solar cells. The bendable devices are composed ...
... , This release is available in Spanish ... a popular native Hawaiian fruit, has been released by U.S. ... cooperators. ,Ōhelo ( Vaccinium reticulatum Smith ) is ... found at high elevations on the islands of Maui and ...
... an effective vaccine for malaria is a step closer following ... to infect human cells. The discovery, by researchers at The ... new vaccine target through which infection with the deadly disease ... people contract malaria, and more than one million, mostly children, ...
Cached Biology News:Mimicking nature, water-based 'artificial leaf' produces electricity 2Scientists release first cultivated ohelo berry for Hawaii 2Malaria's newest pathway into human cells identified 2
Pharmalyte, narrow range pH 4.2-4.9, 25 ml. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Immobiline for IEF and Carrier Ampholytes....
...
...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Biology Products: